#limitation

Collection of limitation news, found 277 news.

Deciphering Indonesia in its myriad shades through its female writers

Weekend Stories

Deciphering Indonesia in its myriad shades through its female writers

  • 7th March 2020

International Women's Day is celebrated worldwide to honor women and their accomplishments and acknowledge what ...

Takeda completes sale of select OTC and non-core assets to Acino

Takeda completes sale of select OTC and non-core assets to Acino

  • 3rd March 2020

- Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced the completion of its ...

Takeda agrees to divest select OTC and non-core assets in Latin America to Hypera Pharma for $825 million USD

Takeda agrees to divest select OTC and non-core assets in Latin America to Hypera Pharma for $825 million USD

  • 3rd March 2020

- Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it has entered into an ...

Aptorum Group commences commercialization of dioscorea opposita bioactive nutraceutical tablets and signed sales distribution agreement in Hong Kong

Aptorum Group commences commercialization of dioscorea opposita bioactive nutraceutical tablets and signed sales distribution agreement in Hong Kong

  • 25th February 2020

- Aptorum Group Limited (“Aptorum Group”), a pharmaceutical company focused on the development of novel ...

Aptorum Group announces significant progress of repurposed drug candidate, SACT-1 for neuroblastoma targeting IND submission in H2 2020

Aptorum Group announces significant progress of repurposed drug candidate, SACT-1 for neuroblastoma targeting IND submission in H2 2020

  • 11th February 2020

- Aptorum Group Limited (Nasdaq: APM) (“Aptorum Group”), a biopharmaceutical company focused on the development of ...

Aptorum Group announces further positive data for its ALS-4 small molecule Anti-virulence (Non-bactericidal) drug candidate for the treatment of infections caused by Staphylococcus aureus and on track

Aptorum Group announces further positive data for its ALS-4 small molecule Anti-virulence (Non-bactericidal) drug candidate for the treatment of infections caused by Staphylococcus aureus and on track

  • 10th February 2020

- Aptorum Group Limited (NASDAQ: APM) (“Aptorum Group”), a biopharmaceutical company focused on the development of ...

PVH Corp. names Tom Chu Regional President, PVH Asia Pacific

PVH Corp. names Tom Chu Regional President, PVH Asia Pacific

  • 9th January 2020

- PVH Corp. (NYSE:PVH), one of the world’s largest apparel companies and owner of iconic brands, including CALVIN ...

Takeda continues strategic divestitures with sale of select OTC and non-core assets to STADA for $660 million USD

Takeda continues strategic divestitures with sale of select OTC and non-core assets to STADA for $660 million USD

  • 5th November 2019

- Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it has entered into an ...

Tommy Hilfiger appoints Michael Scheiner as Global Chief Marketing Officer

Tommy Hilfiger appoints Michael Scheiner as Global Chief Marketing Officer

  • 22nd October 2019

- Tommy Hilfiger, which is owned by PVH Corp. [NYSE: PVH], is pleased to announce the appointment of Michael Scheiner ...

Takeda agrees to divest select OTC and non-core assets to Acino for over $200 million USD

Takeda agrees to divest select OTC and non-core assets to Acino for over $200 million USD

  • 15th October 2019

- Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it has entered into an ...

Aptorum Group has initiated IND-enabling studies for its ALS-4 small molecule candidate for the treatment of infections caused by staphylococcus aureus including MRSA

Aptorum Group has initiated IND-enabling studies for its ALS-4 small molecule candidate for the treatment of infections caused by staphylococcus aureus including MRSA

  • 9th September 2019

- Aptorum Group Limited (Nasdaq: APM) (“Aptorum Group”), a biopharmaceutical company focused on the development of ...

Aptorum Group announces the development of microbiome drug candidate targeting obesity and repurposed drug candidates targeting neuroblastoma

Aptorum Group announces the development of microbiome drug candidate targeting obesity and repurposed drug candidates targeting neuroblastoma

  • 9th September 2019

- Aptorum Group Limited (Nasdaq: APM) (“Aptorum Group”), a biopharmaceutical company focused on the development of ...

RI can balance freedom of speech and national security: Rudiantara

RI can balance freedom of speech and national security: Rudiantara

  • 27th August 2019

Indonesian Minister of Communication and Informatics, Rudiantara, stated at the Antara News Agency office in Jakarta on ...

Aptorum Group’s subsidiary Smart Pharma announces Smart Pharma token (SMPT) to be listed on IDAX and LATOKEN

Aptorum Group’s subsidiary Smart Pharma announces Smart Pharma token (SMPT) to be listed on IDAX and LATOKEN

  • 8th July 2019

- Aptorum Group Limited (Nasdaq: APM) subsidiary Smart Pharmaceutical is excited to announce that the Smart Pharma ...

Patimban port's operator hot race

Opinion

Patimban port's operator hot race

  • 6th July 2019

*Siswanto Rusdi is the director of The National Maritime Institute (NAMARIN) Patimban port project in Subang, West ...